Search research articles
Contact Us
Filters
Showing results (221-230 of 236) with videos related to
Page
of 24
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 16, 2025
Longitudinal Analysis Reveals Dynamic Changes in Histopathologic Features in Responders to Neoadjuvant Treatment in a Stage III BRAF-Mutant Melanoma Cohort
Jorja Braden, Alison Potter, Robert V Rawson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 2021
Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for <i>μ</i>-Opioid Receptor and Opioid-Like Behavioral Effects in Rats
Samuel Obeng, Jenny L Wilkerson, Francisco León, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
Alexander H R Varey, Isabel Li, Mary-Ann El Sharouni, et al.
Annals of Surgical Oncology
|
November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
Caroline A Gjorup, Rachel Woodford, Isabel Li, et al.
Nature Medicine
|
February 9, 2021
Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
Alexander M Menzies, Rodabe N Amaria, Elisa A Rozeman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2026
Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experience
Francis Proulx-Rocray, Rebecca Symons, Yang Wang, et al.
Journal for Immunotherapy of Cancer
|
March 25, 2025
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma
Li Zhou, Milton Jose Barros E Silva, Edward Hsiao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2025
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma
R V Rawson, N G Maher, A M Menzies, et al.
Annals of Surgical Oncology
|
April 15, 2022
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Annals of Surgical Oncology
|
January 28, 2022
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Page
of 24
Search research articles
Search
Showing results (221-230 of 236) with videos related to
Sort By:
Page
of 24
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
April 16, 2025
Longitudinal Analysis Reveals Dynamic Changes in Histopathologic Features in Responders to Neoadjuvant Treatment in a Stage III BRAF-Mutant Melanoma Cohort
Jorja Braden, Alison Potter, Robert V Rawson, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 2021
Pharmacological Comparison of Mitragynine and 7-Hydroxymitragynine: In Vitro Affinity and Efficacy for <i>μ</i>-Opioid Receptor and Opioid-Like Behavioral Effects in Rats
Samuel Obeng, Jenny L Wilkerson, Francisco León, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2024
Predicting Recurrence-Free and Overall Survival for Patients With Stage II Melanoma: The MIA Calculator
Alexander H R Varey, Isabel Li, Mary-Ann El Sharouni, et al.
Annals of Surgical Oncology
|
November 15, 2023
Role of Concurrent Ultrasound Surveillance of Sentinel Node-Positive Node Fields in Melanoma Patients Having Routine Cross-Sectional Imaging
Caroline A Gjorup, Rachel Woodford, Isabel Li, et al.
Nature Medicine
|
February 9, 2021
Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC)
Alexander M Menzies, Rodabe N Amaria, Elisa A Rozeman, et al.
European Journal of Cancer (Oxford, England : 1990)
|
June 10, 2026
Standard neoadjuvant immunotherapy in patients with resectable stage III Melanoma - The early Australian experience
Francis Proulx-Rocray, Rebecca Symons, Yang Wang, et al.
Journal for Immunotherapy of Cancer
|
March 25, 2025
FDG-PET associations with pathological response and survival with neoadjuvant immunotherapy for melanoma
Li Zhou, Milton Jose Barros E Silva, Edward Hsiao, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2025
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma
R V Rawson, N G Maher, A M Menzies, et al.
Annals of Surgical Oncology
|
April 15, 2022
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Annals of Surgical Oncology
|
January 28, 2022
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Page
of 24